Sign In
Buy CRTX
$2.20
+0 (+0%)
At Close: Nov 04, 2022
Benzinga's Top Upgrades, Downgrades For June 2, 2020
01:44pm, Tuesday, 02'nd Jun 2020
Upgrades * For Eaton Vance Corp (NYSE: EV), B of A Securities upgraded the stock from Neutral to Buy. In the second quarter, Eaton Vance showed an EPS of $0.80, compared to $0.89 from the year-ago q
Cortexyme to Present at the Jefferies Virtual Healthcare Conference on June 2, 2020
12:00pm, Wednesday, 27'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimer’s and other degenerative diseases, today announced Casey Lynch, the company
Insider Weekends: Moderna Executives Go On A Selling Spree
03:20pm, Monday, 25'th May 2020
Insider buying decreased significantly last week. Notable Insider Buys: Mercury General Corporation, Cortexyme, Inc., New Mountain Finance Corporation, Berkshir
Are Insiders Buying Cortexyme, Inc. (NASDAQ:CRTX) Stock?
03:44pm, Thursday, 14'th May 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Cortexyme Announces First Quarter 2020 Financial Results and Provides Business Update
08:05pm, Tuesday, 12'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimer’s and other degenerative diseases, today announced financial results for th
Cortexyme Announces First Quarter 2020 Financial Results and Provides Business Update
12:00am, Tuesday, 12'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimer’s and other degenerative di
Cortexyme to Present at the BofA Securities 2020 Health Care Conference on May 13, 2020
12:00pm, Thursday, 07'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimer
Cortexyme to Present at the BofA Securities 2020 Health Care Conference on May 13, 2020
12:00am, Thursday, 07'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it
Cortexyme Publishes Data on P. Gingivalis Ability to Infect Neurons, Drive Alzheimer’s-Like Pathology in the Journal of Alzheimer’s Disease
12:30pm, Wednesday, 06'th May 2020
Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel, disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheime
Cortexyme Appoints Caryn McDowell, J.D. as Chief Legal and Administrative Officer and Corporate Secretary
08:05pm, Thursday, 30'th Apr 2020
Cortexyme, Inc. (Nasdaq: CRTX), a biopharmaceutical company developing treatments for Alzheimer’s disease (AD) and other degenerative diseases, today announced Caryn McDowell, J.D. will join the com
Summit Financial Group Reports First Quarter 2020 Results
10:00am, Thursday, 30'th Apr 2020
MOOREFIELD, W.V., April 30, 2020 -- Summit Financial Group, Inc. (“Company” or “Summit”) (NASDAQ: SMMF) today reported first quarter 2020 net income of $4.51 million, or $0.35.
Further Metallurgical Test Work Continues to Add Improvements and Modeled Revenue Increases at Alpala
12:00pm, Wednesday, 29'th Apr 2020
Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (CGP.V) (GWN.F) (GWN.BE) (CTNXF) is pleased to announce the following update on the exploration program at its Cascabel copp
During Ramadan, our ritual of gathering won’t happen but our values of community remain
04:16pm, Friday, 24'th Apr 2020
This year, we plan on holding our prayers at home as a family and focusing on the blessings of health and wellness despite social distancing.
Cortexyme, Inc. (NASDAQ:CRTX) Position Increased by Bank of New York Mellon Corp
08:58am, Tuesday, 21'st Apr 2020
Bank of New York Mellon Corp boosted its holdings in Cortexyme, Inc. (NASDAQ:CRTX) by 180.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Comm
Cornerstone Reports Significant Increase in Online Learning as Organizations Transition to Remote Work Globally
12:00pm, Friday, 17'th Apr 2020
New data from the Cornerstone Institute for People Development reveals 27.5 million hours were spent on Cornerstone Learning in March 2020.
